Venus Remedies has got all nine facilities approved for GMP by Ukraine a PIC/s nation (Pharmaceutical Inspection Convention/Co-operation Scheme). Venus is the only company who is having a Ukrainian-GMP approval for Large Volume Parenteral for its Panchkula facility in India. The Certification has been granted by National Agency for Food and Drug Administration and Control (NAFDAC). Nine facilities include Cephalosporin inj, carbepenem, oncology liquid injection, oncology lyophilized injection, ampoules, liquid vials, general lyophilized vials, pre-filled syringes and IV fluids.
This certification is an extended recognition for the Company's manufacturing facilities which are at par with the international standards in quality system set by PIC/s nation. This is third time PICs has recognized the quality manufacturing standards of Venus. Now, all the 9 facilities of Venus including eight of Baddi and one of Panchkula are certified with GMP by the NAFDAC, Ukraine (PIC/s Member) thereby opening more opportunities for Venus to expand its product portfolio in remaining PIC member countries.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: